Annual antimicrobial cost savings attributable to a transition toward more narrow-spectrum, lower cost drugs
HA C. difficile infections avoided in 2013 after establishing an ASP targeted at reducing broad spectrum Abx usage
2013 cost avoidance attributable to a lowering HA C. difficile rates house-wide at HDVCH
Hematology/Oncology patients treated at Helen DeVos Children’s Hospital (HDVCH), a 212-bed children’s hospital in Grand Rapids, Mich., are often treated with multiple antimicrobials. Staff became concerned about the level and breadth of Abx usage in Hem/Onc and the related 23.7 hospital acquired C. difficile rate.
The hospital created a targeted antimicrobial stewardship program (ASP) efforts within the Hem/Onc unit by running unit-specific antibiogram through Quality Compass.
The clinical RPh and pediatric infectious disease physicians rounded together on Hem/Onc to make collaborative Abx decisions. Hem/Onc pilot’s success led to house-wide expansion at HDVCH.
Download the case study
The transition resulted in significant cost savings and lower infection rates including:
- Decreased overall Abx usage by 47% between 2012 and 2013
- Saved $449K in Abx costs and infection in 2013
- Lowered HA C. difficile rates by 69% in Hem/Onc and 51% house-wide in 2013
- Received internal funding to expand ASP initiative to Spectrum Health adult hospitals.